US Stock MarketDetailed Quotes

XBIT XBiotech

Watchlist
  • 5.700
  • -0.090-1.55%
Close Jul 5 16:00 ET
  • 5.700
  • 0.0000.00%
Post 16:02 ET
173.61MMarket Cap-5643P/E (TTM)

XBiotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-49.79%-7.2M
-26.32%-18.73M
-8.50%-3.43M
-29.30%-1.49M
-67.01%-9M
6.15%-4.81M
-121.35%-14.82M
-79.87%-3.16M
66.20%-1.15M
-107.40%-5.39M
Net income from continuing operations
-162.11%-10M
25.36%-24.56M
-44.71%-4.64M
41.82%-7.36M
24.92%-8.74M
29.27%-3.82M
-88.93%-32.9M
50.47%-3.2M
-288.16%-12.66M
-127.51%-11.64M
Operating gains losses
513.05%1.58M
-167.61%-1.89M
59.34%-1.25M
-78.16%1.07M
---1.33M
---383K
--2.8M
---3.07M
--4.88M
----
Depreciation and amortization
-2.48%432K
-33.28%1.74M
-2.03%434K
-41.14%432K
-40.17%435K
-37.61%443K
-1.28%2.61M
-36.89%443K
6.84%734K
13.95%727K
Change In working capital
123.05%405K
-64.22%2.72M
-18.34%1.33M
-28.18%3.43M
-108.93%-276K
6.84%-1.76M
-90.47%7.6M
-38.73%1.63M
343.19%4.77M
-95.94%3.09M
-Change in receivables
99.13%-10K
-88.71%829K
-63.68%397K
-74.67%2.46M
53.92%-875K
26.62%-1.16M
323.54%7.34M
-26.50%1.09M
521.33%9.72M
38.68%-1.9M
-Change in prepaid assets
-202.91%-312K
-147.90%-160K
490.00%118K
190.79%69K
-377.27%-244K
-134.11%-103K
194.89%334K
103.58%20K
-1,185.71%-76K
-95.92%88K
-Change in payables and accrued expense
265.23%727K
184.62%2.11M
46.57%812K
119.76%894K
-84.17%843K
28.34%-440K
365.59%741K
345.13%554K
-2,107.32%-4.53M
239.02%5.33M
-Change in other working capital
----
92.76%-59K
--0
--0
--0
---59K
-101.04%-815K
-102.15%-42K
-164.34%-350K
----
Cash from discontinued investing activities
Operating cash flow
-49.79%-7.2M
-26.32%-18.73M
-8.50%-3.43M
-29.30%-1.49M
-67.01%-9M
6.15%-4.81M
-121.35%-14.82M
-79.87%-3.16M
66.20%-1.15M
-107.40%-5.39M
Investing cash flow
Cash flow from continuing investing activities
-4,150.00%-255K
196.25%61.5M
97.06%-115K
203.49%61.83M
-153.66%-208K
96.27%-6K
-1,712.54%-63.89M
-720.80%-3.91M
-8,434.57%-59.74M
95.21%-82K
Net PPE purchase and sale
-4,150.00%-255K
38.12%-362K
12.88%-115K
84.29%-33K
-153.66%-208K
96.27%-6K
83.40%-585K
72.27%-132K
70.00%-210K
95.21%-82K
Net investment purchase and sale
----
197.71%61.86M
--0
----
----
----
---63.31M
---3.78M
----
----
Cash from discontinued investing activities
Investing cash flow
-4,150.00%-255K
196.25%61.5M
97.06%-115K
203.49%61.83M
-153.66%-208K
96.27%-6K
-1,712.54%-63.89M
-720.80%-3.91M
-8,434.57%-59.74M
95.21%-82K
Financing cash flow
Cash flow from continuing financing activities
10.06M
-9K
0
5K
-14K
0
0
0
0
Net issuance payments of debt
--10M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--55K
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
----
--5K
--0
----
----
----
--0
--0
----
----
Net other financing activities
----
---14K
--0
--0
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--10.06M
---9K
--0
--5K
---14K
--0
--0
--0
--0
----
Net cash flow
Beginning cash position
27.16%200.02M
-33.62%157.31M
25.92%202.19M
-36.49%143.39M
-34.22%152.48M
-33.62%157.31M
-0.16%236.98M
-32.78%160.57M
-28.38%225.79M
-3.36%231.82M
Current changes in cash
153.97%2.6M
154.33%42.76M
49.82%-3.55M
199.10%60.34M
-68.57%-9.22M
8.89%-4.81M
-7,134.93%-78.72M
-221.12%-7.07M
20.03%-60.89M
-107.29%-5.47M
Effect of exchange rate changes
-19,675.00%-1.58M
95.21%-46K
-63.77%1.38M
64.37%-1.54M
122.54%126K
-106.56%-8K
-236.31%-961K
1,136.69%3.81M
-1,705.42%-4.33M
-275.79%-559K
End cash Position
31.84%201.04M
27.16%200.02M
27.16%200.02M
25.92%202.19M
-36.49%143.39M
-34.22%152.48M
-33.62%157.31M
-33.62%157.31M
-32.78%160.57M
-28.38%225.79M
Free cash flow
-54.90%-7.46M
-23.87%-19.09M
-7.65%-3.55M
-11.76%-1.52M
-68.31%-9.21M
8.89%-4.81M
-123.38%-15.41M
-47.47%-3.3M
66.85%-1.36M
-107.69%-5.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -49.79%-7.2M-26.32%-18.73M-8.50%-3.43M-29.30%-1.49M-67.01%-9M6.15%-4.81M-121.35%-14.82M-79.87%-3.16M66.20%-1.15M-107.40%-5.39M
Net income from continuing operations -162.11%-10M25.36%-24.56M-44.71%-4.64M41.82%-7.36M24.92%-8.74M29.27%-3.82M-88.93%-32.9M50.47%-3.2M-288.16%-12.66M-127.51%-11.64M
Operating gains losses 513.05%1.58M-167.61%-1.89M59.34%-1.25M-78.16%1.07M---1.33M---383K--2.8M---3.07M--4.88M----
Depreciation and amortization -2.48%432K-33.28%1.74M-2.03%434K-41.14%432K-40.17%435K-37.61%443K-1.28%2.61M-36.89%443K6.84%734K13.95%727K
Change In working capital 123.05%405K-64.22%2.72M-18.34%1.33M-28.18%3.43M-108.93%-276K6.84%-1.76M-90.47%7.6M-38.73%1.63M343.19%4.77M-95.94%3.09M
-Change in receivables 99.13%-10K-88.71%829K-63.68%397K-74.67%2.46M53.92%-875K26.62%-1.16M323.54%7.34M-26.50%1.09M521.33%9.72M38.68%-1.9M
-Change in prepaid assets -202.91%-312K-147.90%-160K490.00%118K190.79%69K-377.27%-244K-134.11%-103K194.89%334K103.58%20K-1,185.71%-76K-95.92%88K
-Change in payables and accrued expense 265.23%727K184.62%2.11M46.57%812K119.76%894K-84.17%843K28.34%-440K365.59%741K345.13%554K-2,107.32%-4.53M239.02%5.33M
-Change in other working capital ----92.76%-59K--0--0--0---59K-101.04%-815K-102.15%-42K-164.34%-350K----
Cash from discontinued investing activities
Operating cash flow -49.79%-7.2M-26.32%-18.73M-8.50%-3.43M-29.30%-1.49M-67.01%-9M6.15%-4.81M-121.35%-14.82M-79.87%-3.16M66.20%-1.15M-107.40%-5.39M
Investing cash flow
Cash flow from continuing investing activities -4,150.00%-255K196.25%61.5M97.06%-115K203.49%61.83M-153.66%-208K96.27%-6K-1,712.54%-63.89M-720.80%-3.91M-8,434.57%-59.74M95.21%-82K
Net PPE purchase and sale -4,150.00%-255K38.12%-362K12.88%-115K84.29%-33K-153.66%-208K96.27%-6K83.40%-585K72.27%-132K70.00%-210K95.21%-82K
Net investment purchase and sale ----197.71%61.86M--0---------------63.31M---3.78M--------
Cash from discontinued investing activities
Investing cash flow -4,150.00%-255K196.25%61.5M97.06%-115K203.49%61.83M-153.66%-208K96.27%-6K-1,712.54%-63.89M-720.80%-3.91M-8,434.57%-59.74M95.21%-82K
Financing cash flow
Cash flow from continuing financing activities 10.06M-9K05K-14K0000
Net issuance payments of debt --10M------------------0----------------
Net common stock issuance --55K------------------0----------------
Proceeds from stock option exercised by employees ------5K--0--------------0--0--------
Net other financing activities -------14K--0--0------------------------
Cash from discontinued financing activities
Financing cash flow --10.06M---9K--0--5K---14K--0--0--0--0----
Net cash flow
Beginning cash position 27.16%200.02M-33.62%157.31M25.92%202.19M-36.49%143.39M-34.22%152.48M-33.62%157.31M-0.16%236.98M-32.78%160.57M-28.38%225.79M-3.36%231.82M
Current changes in cash 153.97%2.6M154.33%42.76M49.82%-3.55M199.10%60.34M-68.57%-9.22M8.89%-4.81M-7,134.93%-78.72M-221.12%-7.07M20.03%-60.89M-107.29%-5.47M
Effect of exchange rate changes -19,675.00%-1.58M95.21%-46K-63.77%1.38M64.37%-1.54M122.54%126K-106.56%-8K-236.31%-961K1,136.69%3.81M-1,705.42%-4.33M-275.79%-559K
End cash Position 31.84%201.04M27.16%200.02M27.16%200.02M25.92%202.19M-36.49%143.39M-34.22%152.48M-33.62%157.31M-33.62%157.31M-32.78%160.57M-28.38%225.79M
Free cash flow -54.90%-7.46M-23.87%-19.09M-7.65%-3.55M-11.76%-1.52M-68.31%-9.21M8.89%-4.81M-123.38%-15.41M-47.47%-3.3M66.85%-1.36M-107.69%-5.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg